Intestinal drug delivery systems with biodegradable microspheres targeting mucosal immune-regulating cells for chronic inflammatory colitis

Journal of Gastroenterology

Volumn 37, Issue SUPPL. 14, 2002, Pages 44-52

  Okazaki, Kazuichi ^a   Nakase, Hiroshi ^a   Watanabe, Norihiko ^a   Tabata, Yasuhiko ^b   Ikada, Yoshito ^b   Chiba, Tsutomu ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Drug delivery system; IBD; Microsphere

Indexed keywords

CLODRONIC ACID; DEXAMETHASONE; GAMMA INTERFERON; GELATIN; INTERLEUKIN 1; INTERLEUKIN 10; MICROSPHERE; MYELOPEROXIDASE; NITRIC OXIDE; POLYLACTIC ACID; SODIUM SULFATE; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIODEGRADABILITY; COLITIS; CONTROLLED STUDY; DOWN REGULATION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG MECHANISM; DRUG SYNTHESIS; DRUG TARGETING; ENZYME ACTIVITY; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; MACROPHAGE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0036854763     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03326413     Document Type: Article

References (34)

1. MacDermott RP, Stenson WF. Alterations of the immune system in ulcerative colitis and Crohn's disease. Adv Immunol 1988;42: 285-328.
2. Podolsky DK. Inflammatory bowel disease. 1. N Engl J Med 1991;325:928-37.
3. Podolsky DK. Inflammatory bowel disease. 2. N Engl J Med 1991;325:1008-16.
4. Sartor RB. Current concept of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Gastroenterol Clin North Am 1995;24:475-507.
5. Sartor RB. Pathogenesis and immune mechanism of chronic inflammatory bowel diseases. Am J Gastroenterol 1997;92:5s-11s.
6. Wilders MN, Drexhage HA, Kokje M. Veiled cells in chronic inflammatory bowel disease. Clin Exp Immunol 1984;55:461-8.
7. Allison MC, Cornwall S, Poulter LW, Dhillon AP, Pounder RE. Macrophage heterogeneity in normal colonic mucosa in inflammatory bowel disease. Gut 1988;29:1531-8.
8. Seldenerijk CA, Drexhage HA, Meuwissen SGM. Dendritic cells and scavenger macrophages in chronic inflammatory bowel disease. Gut 1989;30:484-91.
9. Okazaki K, Morita M, Nishimori I, Sano S, Toyonaga M, Nakazawa Y, et al. Major histocompatibility antigen-restricted cytotoxicity in inflammatory bowel disease. Gastroenterology 1993;104:384-9.
10. Probert CS, Chott A, Turner JR, Saubermann LJ, Stevens AC, Bodinaku K, et al. Persistent clonal expansion of peripheral blood CD4+ lymphocytes in chronic inflammatory bowel disease. J Immunol 1996;157:3183-91.
11. Nakase H, Okazaki K, Tabata Y, Uose S, Ohana M, Uchida K, et al. Development of an oral drug delivery system targeting immueregulating cells in experimental inflammatory bowel disease. J Pharmacol Exp Ther 2000;292:15-21.
12. Nakase H, Okazaki K, Tabata T, Uose S, Ohana M, Uchida K, et al. An oral drug delivery system targeting immune-regulating cells ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis. J Pharmacol Exp Ther 2001;297:122-8.
13. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method for the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990;98:694-702.
14. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of colonic inflammation and ulceration in the rat colon. Gastroenterology 1989;96:795-803.
15. Kühn R, Löhler J, Rennick D, Rajewsky K, Müller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-74.
16. Tabata Y, Ikada Y. Phagocytosis of polymer microspheres by macrophages. Adv Polym Sci 1990;94:107-41.
17. Tabata Y, Inoue Y, Ikada Y. Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres. Vaccine 1996;14:1677-85.
18. Tabata Y, Ikada Y, Morimoto K, Kastumata H, Yabuta T, Iwanaga K, et al. Surfactant-free preparation of biodegradable hydrogel microspheres for protein release. J Bioact Compat Polym 1999;14:371-84.
19. Tran EH, Hoekstra K, van Rooijen N, Dijkstra CD, Owens T. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J Immunol 1998;161:3767-75.
20. Jun HS, Yoon CS, Zbytnuik L, van Rooijen N, Yoon JW. The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Exp Med 1999;189:347-58.
21. Haeberlin B, Rubas W, Holen III HW, Friend DR. In vitro evaluation of dexamethasone-D-glucuronide for colon-specific drug delivery. Pharm Res 1993:10:1553-62.
22. Sadlack B, Merz H, Schorles H, Schimpfl A, Feller AC, Horvak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993;75:253-61.
23. Mombaerts P, Mizoguchi E, Grusby MJ, Glimcher LH, Bhan AK, Tonegawa S. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 1993;75:275-82.
24. i2a-deficient mice. Nat Genet 1995;10:143-9.
25. + T cells. Immunity 1994;1:553-62.
26. Holländer GA, Simpson SJ, Mizoguchi E, Nichogianopoulos A, She J, Gutierrez-Ramos JC, et al. Severe colitis in mice with aberrant thymic selection. Immunity 1995;3:27-38.
27. Nakase H, Okazaki K, Tabata Y, Ozeki M, Watanabe N, Ohana M, et al. New cytokine delivery system using gelatin microspheres containing interleukin-10 for experimental inflammatory bowel disease. J Pharmacol Exp Ther 2002;301:59-65.
28. Fuss IJ, Neurath MF, Boirivant M, Klein JS, de la Motte C, Strong SA, et al. Disparate CD4+ lamina propria lymphokine secretion profiles in inflammatory bowel disease. J Immunol 1996;157:1261-70.
29. Parronchi P, Romagnani P, Annunziato F, Sampugnaro S, Becchio A, Giannarini L, et al. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am J Pathol 1997;150:823-32.
30. Wenner CA, Guler ML, Macatonia SE, O'Garra A, Murphy KM. Role of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development. J Immunol 1996;156:1442-7.
31. Fuss IJ, Marth T, Neurath MF, Perlstein GR, Jain A, Strober W. Anti-interleukin-12 treatment regulates apoptosis of Th1 cells in experimental colitis in mice. Gastroenterology 1999;117:1078-88.
32. Kennedy MK, Picha KS, Fanslow WC, Grabstein KH, Alderson MR, Clifford KN, et al. CD40/CD40 ligand interaction are required for T cell-dependent production of interleukin-12 by mouse macrophages. Eur J Immunol 1996;26:370-8.
33. Battaglia E, Biancone L, Resogotti A, Emanuelli G, Fronda GR, Camussi G. Expression of CD40 and its ligand, CD40L, in intestinal lesions of Crohn's disease. Am J Gastroenterol 1999;94:3279-84.
34. Liu Z, Colpaert S, D'Haens GR, Kasran A, de Boer M, Rutgeerts P, et al. Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production. J Immunol 1999;163:4049-57.